A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity
Clinical trial NCT02567851 · COMPLETED
Trial details
- NCT number
- NCT02567851
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-01-14
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.